Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Site Search
Showing 1 - 10 of 10 results
Press Release
|
Nov. 2, 2011
|
2 min read
Press Release
|
Jan. 31, 2012
|
5 min read
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
June 24, 2014
|
5 min read
Press Release
|
May 17, 2015
|
3 min read
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Press Release
|
Oct. 21, 2019
|
3 min read
Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center.
Close to 40,000 people in the U.S. have cystic fibrosis, a rare genetic disease. The majority of people with CF are diagnosed by age 2 thanks to newborn screening tests. If you have CF or are considering testing for it, knowing about the role of genetics in CF can help you make decisions about your health care.
Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
Press Release
|
July 2, 2015
|
5 min read
Press Release
|
March 18, 2015
|
3 min read
Cystic fibrosis is a genetic disorder that affects the lungs, pancreas, and other organs. Keep reading to learn how to treat and live with CF.